Kurt C. Graves's most recent trade in Seres Therapeutics Inc was a trade of 100,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on April 10, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Seres Therapeutics Inc | Kurt C. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2025 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Seres Therapeutics Inc | Kurt C. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 64,564 | 64,564 | - | - | Stock Option (right to buy) | |
| Seres Therapeutics Inc | Kurt C. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2024 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Seres Therapeutics Inc | Kurt C. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Seres Therapeutics Inc | Kurt C. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 35,000 | 35,000 | - | - | Stock Option (right to buy) |